PharmaSynth AS
CopyRegistry data
Legal status
Company ID
11044101VAT code
EE100940196Registered
29/06/2004Share capital
57,180.00 €Contacts
Company registration address
Website
https://www.pharmasynth.ee
A
HighestReliability
A - Highest
+1 ** during past year
Number of employees
9Credit limit
50-100 k €Credit report
Company's financial performance and creditability assessment.+43.04 % ** during past year
Taxes
91.9KDebts
-+38.56 % ** during past year
Taxable turnover
193.6K
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Data is only provided to registered users with a legitimate interest. |
Financial ratios
Net Profit (€)
Enjoy unlimited use
with Freemium unlimited
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedNet Profit (€)
Register and
explore Okredo dataEBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| 2022 |
|---|
| 475,618 |
| 59,452 |
| 121,436 |
| 121,436 |
| 15,180 |
| 1.16 |
| 0.11 |
| 104.74 |
| 498,158 |
| 99.17 |
| 471,648 |
| 87.05 |
| 25.53 |
| 750,760 |
| 82,591 |
| 197,667 |
| 635,684 |
| 2023 |
|---|
| 635,352 |
| 79,419 |
| 145,484 |
| 145,484 |
| 18,186 |
| 1.16 |
| 0.05 |
| 111.60 |
| 709,078 |
| 103.57 |
| 658,056 |
| 91.17 |
| 22.90 |
| 896,244 |
| 44,535 |
| 157,357 |
| 783,422 |
| 2024 |
|---|
| 586,714 |
| 65,190 |
| 152,148 |
| 152,148 |
| 16,905 |
| 1.52 |
| 0.07 |
| 97.84 |
| 574,018 |
| 90.97 |
| 533,743 |
| 84.76 |
| 25.93 |
| 1,048,392 |
| 75,325 |
| 154,963 |
| 968,754 |
| 2024 |
|---|
| 586,714 |
| 65,190 |
| 152,148 |
| 152,148 |
| 16,905 |
| 1.52 |
| 0.07 |
| 97.84 |
| 574,018 |
| 90.97 |
| 533,743 |
| 84.76 |
| 25.93 |
| 1,048,392 |
| 75,325 |
| 154,963 |
| 968,754 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
Enjoy unlimited use
with Freemium unlimitedCredit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Example report (PDF)
Similar companies
Company's name | Activity | Legal status |
|---|---|---|
Nordaid OÜ Harju maakond, Tallinn, Haabersti linnaosa, Härgmäe tn 22, 12082150 | Manufacture of basic pharmaceutical products | Registered |
Category:
Manufacture of basic pharmaceutical productsComp. code:
12082150Reg. date:
29/03/2011Turnover:
-No. of employees:
7Frequently Asked Questions
What is the current status of PharmaSynth AS?
PharmaSynth AS is currently Registered. It was registered on 29/06/2004.
Where is PharmaSynth AS located?
PharmaSynth AS is registered at Tartu maakond, Tartu linn, Tartu linn, Teaduspargi tn 7.
What does PharmaSynth AS do?
PharmaSynth AS operates in the Manufacture of basic pharmaceutical products (21101 - EMTAK 2025) sector.
How many employees does PharmaSynth AS have?
PharmaSynth AS had 9 employees in 2025 I.
What is the annual turnover of PharmaSynth AS?
PharmaSynth AS reported a turnover of 586,714 EUR in 2024.
What is the net profit of PharmaSynth AS?
PharmaSynth AS reported a net profit of 152,148 EUR in 2024.
Is PharmaSynth AS a reliable company?
PharmaSynth AS Pre-Score* rating is A, which indicates the highest level of reliability.
* The credit score is calculated based on financial data, payment history, and other risk indicators.Does PharmaSynth AS have any unpaid debts?
PharmaSynth AS has no recorded unpaid debts.